Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and “Reopening”.

In COVID-19, Latest News
by ClinOwl May 4, 2021

Projections of the stage of the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pandemic and local, regional and national public health policies to limit coronavirus spread as well as “reopen” cities and […]

Read More

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Factors ID’d for Strong Antibody Response in COVID-19

COVID-19 Pandemic Challenges Osteoporosis Management

AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

Survival From COVID-19 High in Patients With Psoriasis

FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and “Reopening”.